160 related articles for article (PubMed ID: 32631377)
1. Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study.
Amanya SB; Nyiro B; Waswa F; Obura B; Nakaziba R; Nabulime E; Katabazi AF; Nabatanzi R; Bayiyana A; Mboowa G; Kayongo A; Wayengera M; Sande OJ
Retrovirology; 2020 Jul; 17(1):19. PubMed ID: 32631377
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.
Chan E; Schaller T; Eddaoudi A; Zhan H; Tan CP; Jacobsen M; Thrasher AJ; Towers GJ; Qasim W
Hum Gene Ther; 2012 Nov; 23(11):1176-85. PubMed ID: 22909012
[TBL] [Abstract][Full Text] [Related]
5. Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning.
Cloherty APM; Rader AG; Compeer B; Ribeiro CMS
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669846
[TBL] [Abstract][Full Text] [Related]
6. TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection.
Selyutina A; Simons LM; Kirby KA; Bulnes-Ramos A; Hu P; Sarafianos SG; Hultquist JF; Diaz-Griffero F
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215956
[TBL] [Abstract][Full Text] [Related]
7. The cyclophilin A-binding loop of the capsid regulates the human TRIM5α sensitivity of nonpandemic HIV-1.
Twizerimana AP; Becker D; Zhu S; Luedde T; Gohlke H; Münk C
Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2306374120. PubMed ID: 37983491
[TBL] [Abstract][Full Text] [Related]
8. Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1.
Désaulniers K; Ortiz L; Dufour C; Claudel A; Plourde MB; Merindol N; Berthoux L
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375604
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
10. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
[TBL] [Abstract][Full Text] [Related]
11. Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.
Selyutina A; Persaud M; Simons LM; Bulnes-Ramos A; Buffone C; Martinez-Lopez A; Scoca V; Di Nunzio F; Hiatt J; Marson A; Krogan NJ; Hultquist JF; Diaz-Griffero F
Cell Rep; 2020 Mar; 30(11):3766-3777.e6. PubMed ID: 32187548
[TBL] [Abstract][Full Text] [Related]
12. Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection.
Nakajima T; Nakayama EE; Kaur G; Terunuma H; Mimaya JI; Ohtani H; Mehra N; Shioda T; Kimura A
AIDS; 2009 Oct; 23(16):2091-100. PubMed ID: 19710594
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
[TBL] [Abstract][Full Text] [Related]
14. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
15. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
16. The control of viral infection by tripartite motif proteins and cyclophilin A.
Towers GJ
Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686
[TBL] [Abstract][Full Text] [Related]
17. [Retrovirus Restriction Factor TRIM5α: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection].
Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
Mol Biol (Mosk); 2020; 54(5):707-717. PubMed ID: 33009785
[TBL] [Abstract][Full Text] [Related]
18. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
19. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.
Price H; Lacap P; Tuff J; Wachihi C; Kimani J; Ball TB; Luo M; Plummer FA
AIDS; 2010 Jul; 24(12):1813-21. PubMed ID: 20588169
[TBL] [Abstract][Full Text] [Related]
20. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Burse M; Shi J; Aiken C
PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]